Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00354822
Status:
TERMINATED
Last Update Posted:
2009-09-18
First Post:
2006-07-19
Brief Title:
FludarabineCyclophosphamide and Rituximab Followed by Zevalin for Non-Follicular Indolent Lymphomas
Sponsor:
AO Ospedale Papa Giovanni XXIII
Organization:
AO Ospedale Papa Giovanni XXIII
Organization Data
Organization:
AO Ospedale Papa Giovanni XXIII
Class:
OTHER
Study ID:
EUDRACT 2005-000699-41
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AO Ospedale Papa Giovanni XXIII
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Corrado Tarella MD
Old Organization:
Gruppo Per Le Terapie Innovatove nei Linfomi GITIL
Collaborators
| Name | Class |
|---|---|
| Regional Hospital of Bolzano | OTHER |